# Kemia

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/kemia

- Industry: Biotechnology
- Headquarters: San Diego, US
- Total disclosed funding: $81M
- Latest round: Series C (Aug 8, 2006)
- Investors on record: 9

## About

Founded in 2001 and based in San Diego, California, Kemia Inc. operates as a biopharmaceutical company that offers allosteric kinase inhibitors for the treatment of inflammatory diseases, such as rheumatoid arthritis, as well as for cardiovascular and metabolic conditions.

## Funding rounds

- Series C, Aug 8, 2006, $31M — Alta Partners, Forward Ventures, Aberdare Ventures, Novartis Venture Fund, Hamilton BioVentures, Red Abbey, JP Morgan Asset Management, TPG Biotech, Novo Holdings
- Series B, Mar 29, 2004, $34M — Alta Partners, Forward Ventures, Novartis Venture Fund, Hamilton BioVentures, JP Morgan Asset Management, TPG Biotech, Novo Holdings
- Series A, May 1, 2002, $17M — Alta Partners, Forward Ventures, Novartis Venture Fund, TPG Biotech

## Investors

- Alta Partners (https://capitalatlas.ai/funds/alta-partners) — Series A, Series B, Series C
- Forward Ventures (https://capitalatlas.ai/funds/forward-ventures) — Series A, Series B, Series C
- Novartis Venture Fund (https://capitalatlas.ai/funds/novartis-venture-fund) — Series A, Series B, Series C
- TPG Biotech (https://capitalatlas.ai/funds/tpg-biotech) — Series A, Series B, Series C
- Hamilton BioVentures (https://capitalatlas.ai/funds/hamilton-bioventures) — Series B, Series C
- JP Morgan Asset Management (https://capitalatlas.ai/funds/jp-morgan-asset-management) — Series B, Series C
- Novo Holdings — Series B, Series C
- Aberdare Ventures (https://capitalatlas.ai/funds/aberdare-ventures) — Series C
- Red Abbey (https://capitalatlas.ai/funds/red-abbey) — Series C